Dogwood Therapeutics (DWTX) to Release Quarterly Earnings on Wednesday

Dogwood Therapeutics (NASDAQ:DWTX) is expected to announce its earnings results before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($1.36) per share for the quarter.

Dogwood Therapeutics Stock Down 2.9 %

NASDAQ DWTX opened at $5.95 on Wednesday. The firm has a market cap of $7.91 million, a price-to-earnings ratio of -0.91 and a beta of 1.92. The stock has a fifty day moving average of $5.57. Dogwood Therapeutics has a 52-week low of $1.62 and a 52-week high of $29.28.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.